NCT07603102 Mindfulness With Dual-Task Training in Post-Stroke Mild Cognitive Impairment
| NCT ID | NCT07603102 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nanjing Mingzhou Rehabilitation Hospital |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-05-01 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-05-01 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to investigate whether a combined intervention of mindfulness and dual-task training can improve cognitive function and physical performance in individuals with mild cognitive impairment after stroke.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of stroke confirmed by computed tomography (CT) or magnetic resonance imaging (MRI). * Time since stroke onset ≥3 months and medically stable. * Presence of mild cognitive impairment after stroke, defined by a Montreal - - Montreal Cognitive Assessment (MoCA) score \< 26. * Mini-Mental State Examination (MMSE) score ≥ 24. * Ability to walk independently with or without an assistive device for at least 10 meters. * Stable medication regimen for at least 4 weeks prior to enrollment. * Ability to understand study instructions and provide written informed consent. Exclusion Criteria: * Severe aphasia, visual impairment, hearing impairment, or communication disorders that interfere with assessment or training participation. * Severe depression or other major psychiatric disorders. * Other neurological diseases affecting cognition or movement (e.g., Parkinson's disease, multiple sclerosis, traumatic brain injury). * Severe musculoskeletal, cardiovascular, or systemic diseases that contraindicate exercise participation. * Participation in other structured cognitive or rehabilitation intervention programs within the past 3 months. * Unstable medical condition or recurrent stroke during the study period. * Inability to safely complete the training protocol as determined by the study investigators.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07603102 clinical trial?
This trial is open to participants of all sexes, aged 55 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07603102 currently recruiting?
Yes, NCT07603102 is actively recruiting participants. Contact the research team at 170787717@qq.com for enrollment information.
Where is the NCT07603102 trial being conducted?
This trial is being conducted at Nanjing, China.
Who is sponsoring the NCT07603102 clinical trial?
NCT07603102 is sponsored by Nanjing Mingzhou Rehabilitation Hospital. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.